BCDA

BioCardia, Inc. - Common Stock (BCDA)

About BioCardia, Inc. - Common Stock (BCDA)

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Details

Daily high

$1.37

Daily low

$1.26

Price at open

$1.29

52 Week High

$3.20

52 Week Low

$1.00

Market cap

13.8M

Dividend yield

0.00%

Volume

67,507

Avg. volume

67,649

P/E ratio

-.75

BioCardia, Inc. - Common Stock News